We are pleased to announce a new partnership with ZipTrials! They provide a wonderful resource for patients looking to enroll in a clinical trial, along with excellent blog posts and news updates on all things healthcare. For more information visit www.ziptrials.us
ZipTrials is very excited to be partnering up with NeedyMeds.org! A unique clinical trial registration site, ZipTrials makes it easy to enroll in medical research studies. In fact, it only takes three clicks. Showcasing a diverse offering of available clinical trials, ZipTrials features easy-to-use functionality and 24/7 availability.
Not only is the registration process seamless, it’s also 100 percent confidential – ZipTrials does not share any personal or private user information or medical history.
ZipTrials works closely with medical research facilities to find study participants quickly, while also educating the public about the unmatched benefits of such medical research. And unlike other clinical trial recruitment sites, we reinforce these efforts through aggressive advertising in key markets to make sure we’re highly visible to a broad cross-section of the general public. ZipTrials gives our clients a competitive edge when it comes to recruiting volunteers, and they continue to work with us because they see results.
In addition, ZipTrials is a trusted source for the most up-to-date medical news and trending health stories. Our reporters are in the thick of it, covering the most recent and newsworthy clinical trial news.
Since its inception in 2011, ZipTrials has grown significantly. We are continually establishing vital relationships with new medical facilities while delivering unparalleled response rates to existing clients. And our ever-expanding reach continues to acquire new markets across the United States, and eventually beyond.
ZipTrials is part of Metro US, the nation’s most read free daily newspaper. With a proudly metropolitan tone and urban style, Metro is written and designed for young, ambitious professionals and features a mix of hard-hitting news and colorful features. Metro reaches 1.2 million readers in New York, Boston and Philadelphia.
